The Biomarkers Industry, valued at USD 66.8 billion in 2022, is projected to experience substantial growth over the next several years. By 2030, the market is expected to reach USD 182.6 billion, expanding at a compound annual growth rate (CAGR) of 13.4% from 2023 to 2030. Biomarkers, which are biological molecules found in blood, other body fluids, or tissues, serve as indicators of...